Evidence map›Paper›PMID 26748024›Full record

ArticleNeurobiology of learning and memory2016

Fear potentiated startle increases phospholipase D (PLD) expression/activity and PLD-linked metabotropic glutamate receptor mediated post-tetanic potentiation in rat amygdala.

Balaji Krishnan, Michael T Scott, Sebastian Pollandt, Bradley Schroeder, Alexander Kurosky, Patricia Shinnick-Gallagher

Abstract read
In one paragraph

Article in Neurobiology of learning and memory, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Balaji KrishnanDepartment of Pharmacology & Toxicology, University of Texas Medical Branch, Galveston, TX, United States; UTMB Mitchell Center for Neurodegenerative Diseases, Department of Neurology, University of Texas Medical Branch, Galveston, TX, United States. Electronic address: bakrishn@utmb.edu.
Michael T ScottDepartment of Pharmacology & Toxicology, University of Texas Medical Branch, Galveston, TX, United States.
Sebastian PollandtDepartment of Pharmacology & Toxicology, University of Texas Medical Branch, Galveston, TX, United States.
Bradley SchroederDepartment of Pharmacology & Toxicology, University of Texas Medical Branch, Galveston, TX, United States.
Alexander KuroskyUTMB NHLBI Proteomics Center, Department of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX, United States.
Patricia Shinnick-GallagherDepartment of Pharmacology & Toxicology, University of Texas Medical Branch, Galveston, TX, United States.
The University of Texas Medical Branch at Galveston · US

Funding

Lipase in Cocaine Cue Associations in the AmygdalaF32DA023316 · NIDA · UNIVERSITY OF TEXAS MED BR GALVESTON · PI KRISHNAN, BALAJI · 2007 to 2009
$170k
Relapse and 5-HT2CR-PLD signaling in rat amygdalaR03DA033428 · NIDA · UNIVERSITY OF TEXAS MED BR GALVESTON · PI KRISHNAN, BALAJI · 2013 to 2013
$116k
NHLBI NIH HHS HHSN268201000037CNHLBI NIH HHS N01-HV-00245NIDA NIH HHS DA023316NIDA NIH HHS F32 DA023316NIDA NIH HHS R03 DA033428PHS HHS NIDA R03 DA033428
6 · The paper itself

Abstract

Long-term memory (LTM) of fear stores activity dependent modifications that include changes in amygdala signaling. Previously, we identified an enhanced probability of release of glutamate mediated signaling to be important in rat fear potentiated startle (FPS), a well-established translational behavioral measure of fear. Here, we investigated short- and long-term synaptic plasticity in FPS involving metabotropic glutamate receptors (mGluRs) and associated downstream proteomic changes in the thalamic-lateral amygdala pathway (Th-LA). Aldolase A, an inhibitor of phospholipase D (PLD), expression was reduced, concurrent with significantly elevated PLD protein expression. Blocking the PLD-mGluR signaling significantly reduced PLD activity. While transmitter release probability increased in FPS, PLD-mGluR agonist and antagonist actions were occluded. In the unpaired group (UNP), blocking the PLD-mGluR increased while activating the receptor decreased transmitter release probability, consistent with decreased synaptic potentials during tetanic stimulation. FPS Post-tetanic potentiation (PTP) immediately following long-term potentiation (LTP) induction was significantly increased. Blocking PLD-mGluR signaling prevented PTP and reduced cumulative PTP probability but not LTP maintenance in both groups. These effects are similar to those mediated through mGluR7, which is co-immunoprecipitated with PLD in FPS. Lastly, blocking mGluR-PLD in the rat amygdala was sufficient to prevent behavioral expression of fear memory. Thus, our study in the Th-LA pathway provides the first evidence for PLD as an important target of mGluR signaling in amygdala fear-associated memory. Importantly, the PLD-mGluR provides a novel therapeutic target for treating maladaptive fear memories in posttraumatic stress and anxiety disorders.

Indexed as

Long-Term PotentiationAmygdalaAnimalsConditioning, ClassicalCyclopropanesElectric StimulationExcitatory Postsynaptic PotentialsFearFructose-Bisphosphate AldolaseGlycineMaleMemory, Long-TermNeural PathwaysPhospholipase DRatsRats, Sprague-Dawley2-(2'-carboxy-3'-phenylcyclopropyl)glycineCyclopropanesFructose-Bisphosphate AldolaseGlycinePhospholipase DReceptors, Metabotropic GlutamateAmygdala memory mechanismsFear potentiated startleNeuropharmacologyNeurophysiologyPhospholipase DProteomic studies

Identifiers

PMID26748024
PMCPMC4744522
OpenAlexW2210263619

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.